国立研究開発法人国立国際医療研究センターは、日本の厚生労働省所管の国立研究開発法人で、国立高度専門医療研究センターである。 2010年4月1日、「高度専門医療に関する研究等を行う独立行政法人に関する法律」に基づき、厚生労働省所管の施設等機関であった国立国際医療センターが組織移行する形で発足した。

During the past decade, Global Health and Medicine Ctr conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Global Health and Medicine Ctr" #1 sponsor was "Boehringer Ingelheim" with 3 trials, followed by "AstraZeneca" with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored, "Kiminori Kimura, MD" with 1 trials sponsored and "Takeda" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Global Health and Medicine Ctr" #1 collaborator was "Japan Agency for Medical Research and Development" with 1 trials as a collaborator, "Kyushu University" with 1 trials as a collaborator, "National Center for Global Health and Medicine, Japan" with 1 trials as a collaborator, "Ohara Pharmaceutical Co., Ltd." with 1 trials as a collaborator and "Prism Pharma Co., Ltd." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Global Health and Medicine Ctr" are "Asthma" (1 trials), "Atrial Fibrillation" (1 trials), "Erosive Esophagitis" (1 trials), "Hepatitis B" (1 trials) and "Hepatitis C" (1 trials). Many other conditions were trialed in "Global Health and Medicine Ctr" in a lesser frequency.

Most popular intervention types in "Global Health and Medicine Ctr" are "Drug" (6 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Aspirin" (1 trials), "Clopidogrel or Ticagrelor" (1 trials), "Dabigatran Etexilate 110mg" (1 trials) and "Dabigatran Etexilate 150mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Global Health and Medicine Ctr" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Global Health and Medicine Ctr". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Global Health and Medicine Ctr, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Global Health and Medicine Ctr, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".